Caricamento...
The Strange Case of CDK4/6 Inhibitors: Mechanisms, Resistance, and Combination Strategies
CDK4/6 inhibitors have emerged as a powerful class of agents with clinical activity in a number of malignancies. Targeting the cell cycle represents a core attack on a defining feature of cancer. However, the mechanisms through which selective CDK4/6 targeted agents act has few parallels in the curr...
Salvato in:
| Pubblicato in: | Trends Cancer |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5347397/ https://ncbi.nlm.nih.gov/pubmed/28303264 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trecan.2016.11.006 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|